Medtech Archives - Life Sciences Times

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

THIS WEEK'S STORIES

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

Kopin Advances NeuralDisplay™ Prototype with Breakthrough Hardware and Software Milestones

June 3, 2025

Wolters Kluwer Survey Finds Health Systems Unprepared to Fully Leverage Generative AI

June 3, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

Study Highlights Major Advantages of PharmaJet’s Needle-Free Tropis® ID System in Nigeria’s Polio Vaccination Efforts

Foldax Receives Indian Approval for First-Ever Commercial Polymer Mitral Heart Valve

Gore Launches 0.5 mL Silicone-Free Plunger for Ophthalmic Pre-Filled Syringes

ZOLL and Simon’s Heart Donate AEDs to 32 Youth Organizations Nationwide in Honor of CPR and AED Awareness Week

Muse Launches Athena Headband, Ushering in AI-Powered Sleep and Brain Health Diagnostics

Most Read

IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders

Charter Next Generation Names Lisa Alteri as Chief Operating Officer to Drive Operational Strategy and Growth

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds

EDITOR PICKS

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

THIS WEEK'S STORIES

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

Kopin Advances NeuralDisplay™ Prototype with Breakthrough Hardware and Software Milestones

Wolters Kluwer Survey Finds Health Systems Unprepared to Fully Leverage Generative AI

POPULAR CATEGORY

ABOUT US

FOLLOW US